Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Canaday

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Cell Reports. Medicine|June 7, 2021
Vaccine-induced ICOS<sup>+</sup>CD38<sup>+</sup> circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathwaysRamin Sedaghat Herati, Luisa Victoria Silva, Laura A Vella, et al.
Ebiomedicine|June 11, 2024
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccinationStefan Gravenstein, Frank DeVone, Oladayo A Oyebanji, et al.
Journal of the American Geriatrics Society|August 17, 2023
Neutralization and binding antibody response to second bivalent COVID-19 vaccination in nursing home residentsOladayo A Oyebanji, Yasin Abul, Brigid M Wilson, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccinationDavid H Canaday, Oladayo A Oyebanji, Elizabeth White, et al.
Ebiomedicine|May 23, 2022
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residentsDavid H Canaday, Oladayo A Oyebanji, Elizabeth White, et al.
Aging Clinical and Experimental Research|March 7, 2025
COVID-19 booster doses reduce sex disparities in antibody responses among nursing home residentsOladayo A Oyebanji, Anna Yin, Nicholas Sundheimer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2022
Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA VaccinationDavid H Canaday, Oladayo A Oyebanji, Debbie Keresztesy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2021
Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home ResidentsDavid H Canaday, Lenore Carias, Oladayo A Oyebanji, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residentsDavid H Canaday, Lenore Carias, Oladayo A Oyebanji, et al.
Ebiomedicine|July 14, 2020
A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infectionJamie F S Mann, Joshua Pankrac, Katja Klein, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Cell Reports. Medicine|June 7, 2021
Vaccine-induced ICOS<sup>+</sup>CD38<sup>+</sup> circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathwaysRamin Sedaghat Herati, Luisa Victoria Silva, Laura A Vella, et al.
Ebiomedicine|June 11, 2024
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccinationStefan Gravenstein, Frank DeVone, Oladayo A Oyebanji, et al.
Journal of the American Geriatrics Society|August 17, 2023
Neutralization and binding antibody response to second bivalent COVID-19 vaccination in nursing home residentsOladayo A Oyebanji, Yasin Abul, Brigid M Wilson, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccinationDavid H Canaday, Oladayo A Oyebanji, Elizabeth White, et al.
Ebiomedicine|May 23, 2022
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residentsDavid H Canaday, Oladayo A Oyebanji, Elizabeth White, et al.
Aging Clinical and Experimental Research|March 7, 2025
COVID-19 booster doses reduce sex disparities in antibody responses among nursing home residentsOladayo A Oyebanji, Anna Yin, Nicholas Sundheimer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2022
Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA VaccinationDavid H Canaday, Oladayo A Oyebanji, Debbie Keresztesy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2021
Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home ResidentsDavid H Canaday, Lenore Carias, Oladayo A Oyebanji, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residentsDavid H Canaday, Lenore Carias, Oladayo A Oyebanji, et al.
Ebiomedicine|July 14, 2020
A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infectionJamie F S Mann, Joshua Pankrac, Katja Klein, et al.
Pageof 13